SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001823239-21-000023
Filing Date
2021-09-03
Accepted
2021-09-03 16:05:57
Documents
15
Period of Report
2021-09-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20210902.htm   iXBRL 8-K 48158
2 EX-2.1 exhibit21-amendmentno1tome.htm EX-2.1 38558
3 EX-10.1 exhibit101tovoyagerclosing.htm EX-10.1 17046
4 image_0.jpg GRAPHIC 161
  Complete submission text file 0001823239-21-000023.txt   262342

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20210902.xsd EX-101.SCH 1899
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20210902_lab.xml EX-101.LAB 25848
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20210902_pre.xml EX-101.PRE 13579
8 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20210902_htm.xml XML 12608
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 211236495
SIC: 2834 Pharmaceutical Preparations